The vaccine Glovax will produce is the EuCorVac-19, developed by the United States-based Pop Biotechnologies and produced by its Korean partners Eubiologics and LG Chem. Vaccine makers tend to supply their host countries and the rich states first, “that is why it is very timely that we are suggesting to have a local vaccine plant,” Alingog said. A local vaccine plant would also boost the country’s economy, he noted. Alingog is confident the vaccine plant will become a legacy of the administration of President Rodrigo Duterte in the fight against the coronavirus pandemic. She said the pandemic highlighted the need for the country to ensure a steady source of vaccines, so building a local vaccine plant is a welcome development.

Source: Manila Times March 14, 2021 16:29 UTC